Phosphodiesterase Inhibitor: Clinical Trials

2 trials for Phosphodiesterase Inhibitor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 41Terminated 1

Follow Phosphodiesterase Inhibitor: new trials by email Literature Review of Phosphodiesterase Inhibitor trials Research Report on Phosphodiesterase Inhibitor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of the Hemodynamic Interactions of TPN171H Tablets & Alcohol in Healthy Male Subjects
TPN171H tablet plus alcohol, alcohol, TPN171H tablet - Alcohol, Phosphodiesterase Inhibitor
Phase 1CompletedVigonvita Life Sciences192022-02-242022-05-23
The Effects of Enoximone in Acute Exacerbation COPD
Enoximone - COPD Exacerbation, Enoximone
Phase 4TerminatedRijnstate Hospital32020-05-122022-01-13

Narrower conditions

Erectile Dysfunction (1)

Broader conditions

Genital Diseases (1)  ·  Genital Diseases, Male (1)  ·  Male Urogenital Diseases (1)  ·  Mental Disorders (1)  ·  Sexual Dysfunction, Physiological (1)  ·  Sexual Dysfunctions, Psychological (1)  ·  Urogenital Diseases (1)

Interventions

Enoximone (1)  ·  Ethanol (1)

Sponsors

Rijnstate Hospital (1)  ·  Vigonvita Life Sciences (1)

Countries

China (1)  ·  Netherlands (1)

Top investigators

Chen Yu (1)